Review article · 2024 · Open access
Artificial intelligence-driven pharmaceutical industry: A paradigm shift in drug discovery, formulation development, manufacturing, quality control, and post-market surveillance
European Journal of Pharmaceutical Sciences, 203, 106938 · Published 16 October 2024 · DOI 10.1016/j.ejps.2024.106938
In brief
“Artificial intelligence-driven pharmaceutical industry: A paradigm shift in drug discovery, formulation development, manufacturing, quality control, and post-market surveillance” is a 2024 review article by Kampanart Huanbutta and 6 co-authors, published in European Journal of Pharmaceutical Sciences. OpenAlex counts 194 citations as of 15 November 2026. It is open access under a CC BY-NC licence: the full text is free to read at European Journal of Pharmaceutical Sciences.
- Citations
- 194
- Most cited in
- 2026 (104)
- Field-weighted impact
- 4.97
- References
- 162
- Authors
- 7
Abstract
The advent of artificial intelligence (AI) has catalyzed a profound transformation in the pharmaceutical industry, ushering in a paradigm shift across various domains, including drug discovery, formulation development, manufacturing, quality control, and post-market surveillance. This comprehensive review examines the multifaceted impact of AI-driven technologies on all stages of the pharmaceutical life cycle. It discusses the application of machine learning algorithms, data analytics, and predictive modeling to accelerate drug discovery processes, optimize formulation development, enhance manufacturing efficiency, ensure stringent quality control measures, and revolutionize post-market surveillance methodologies. By describing the advancements, challenges, and future prospects of harnessing AI in the pharmaceutical landscape, this review offers valuable insights into the evolving dynamics of drug development and regulatory practices in the era of AI-driven innovation.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Huanbutta, K., Burapapadh, K., Kraisit, P., Sriamornsak, P., Ganokratanaa, T., Suwanpitak, K., & Sangnim, T. (2024). Artificial intelligence-driven pharmaceutical industry: A paradigm shift in drug discovery, formulation development, manufacturing, quality control, and post-market surveillance. European Journal of Pharmaceutical Sciences, 203, 106938. https://doi.org/10.1016/j.ejps.2024.106938
MLA 9
Huanbutta, Kampanart, et al. “Artificial intelligence-driven pharmaceutical industry: A paradigm shift in drug discovery, formulation development, manufacturing, quality control, and post-market surveillance.” European Journal of Pharmaceutical Sciences, vol. 203, 2024, p. 106938. https://doi.org/10.1016/j.ejps.2024.106938.
Chicago
Huanbutta, Kampanart, Kanokporn Burapapadh, Pakorn Kraisit, Pornsak Sriamornsak, Thittaporn Ganokratanaa, Kittipat Suwanpitak, and Tanikan Sangnim. 2024. “Artificial intelligence-driven pharmaceutical industry: A paradigm shift in drug discovery, formulation development, manufacturing, quality control, and post-market surveillance.” European Journal of Pharmaceutical Sciences 203: 106938. https://doi.org/10.1016/j.ejps.2024.106938.
Harvard
Huanbutta, K. et al. (2024) ‘Artificial intelligence-driven pharmaceutical industry: A paradigm shift in drug discovery, formulation development, manufacturing, quality control, and post-market surveillance’, European Journal of Pharmaceutical Sciences, 203, p. 106938. doi:10.1016/j.ejps.2024.106938.
IEEE
K. Huanbutta et al., “Artificial intelligence-driven pharmaceutical industry: A paradigm shift in drug discovery, formulation development, manufacturing, quality control, and post-market surveillance,” European Journal of Pharmaceutical Sciences, vol. 203, p. 106938, 2024, doi: 10.1016/j.ejps.2024.106938.
BibTeX
@article{huanbutta2024artificial,
title = {{Artificial intelligence-driven pharmaceutical industry: A paradigm shift in drug discovery, formulation development, manufacturing, quality control, and post-market surveillance}},
author = {Huanbutta, Kampanart and Burapapadh, Kanokporn and Kraisit, Pakorn and Sriamornsak, Pornsak and Ganokratanaa, Thittaporn and Suwanpitak, Kittipat and Sangnim, Tanikan},
journal = {European Journal of Pharmaceutical Sciences},
year = {2024},
volume = {203},
pages = {106938},
doi = {10.1016/j.ejps.2024.106938},
url = {https://doi.org/10.1016/j.ejps.2024.106938}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2015 | 1 | |
| 2024 | 6 | |
| 2025 | 83 | |
| 2026 | 104 |
Its field-weighted citation impact is 4.97: it has been cited 4.97 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- artificial intelligence in pharmaceuticals
- drug discovery
- drug formulation development
- pharmaceutical manufacturing
- quality control
- post-marketing surveillance
- machine learning
- predictive modeling
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Huanbutta, K., Burapapadh, K., Kraisit, P., Sriamornsak, P., Ganokratanaa, T., Suwanpitak, K., & Sangnim, T. (2024). Artificial intelligence-driven pharmaceutical industry: A paradigm shift in drug discovery, formulation development, manufacturing, quality control, and post-market surveillance. European Journal of Pharmaceutical Sciences, 203, 106938. https://doi.org/10.1016/j.ejps.2024.106938
How many times has this paper been cited?
194 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at European Journal of Pharmaceutical Sciences.
Who wrote this paper?
Kampanart Huanbutta, Kanokporn Burapapadh, Pakorn Kraisit, Pornsak Sriamornsak, Thittaporn Ganokratanaa, Kittipat Suwanpitak, Tanikan Sangnim.
What is the DOI of this paper?
10.1016/j.ejps.2024.106938. The permanent link is https://doi.org/10.1016/j.ejps.2024.106938.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.